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A Thai patient with methylmalonic acidemia (MMA) and no methylmalonyl-CoA mutase (MCM, EC 5.4.99.2) activity in
leukocytes in the presence of deoxyadenosyl cobalamin (mut0) was found to be heterozygous for two novel mutations: 1048delT and
1706_1707delGGinsTA (G544X), inherited from her mother and father, respectively. The proband was also heterozygous for the
polymorphism, A499T, which did not aﬀect the activity of recombinant MCM.
 2003 Elsevier Science (USA). All rights reserved.Introduction
Methylmalonic acidemia (MMA, MIM 251000) is a
form of metabolic acidosis caused by a defect in propi-
onate metabolism at the step of conversion of methyl-
malonyl-CoA to succinyl-CoA [1]. MMA is caused by a
functional defect in the methylmalonyl-CoA mutase
(MCM, EC 5.4.99.2), which converts L-methylmalonyl-
CoA to succinyl-CoA, due either to a mutation of its
gene (mut0 or mut) or to a defect in metabolism of its
cofactor, deoxyadenosyl cobalamin (cbl A-H) [1–3].
So far, over 50 disease-causing mut mutations have
been identiﬁed, along with many polymorphisms [4–10].
Several mut mutations have been identiﬁed in Japanese
patients [11,12], but relatively little has been done in the
rest of Asia. Here, we have identiﬁed the ﬁrst Thai case
of mut0 MMA to be conﬁrmed at the molecular level,
identifying two novel mutations.* Corresponding author. Fax: +66-2-248-0375.
E-mail address: scjsv@mahidol.ac.th (J. Svasti).
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Patient
The female infant of unrelated Thai parents presented
at age 2 days with tachypnea and lethargy. Laboratory
data indicated severe metabolic acidosis with a very wide
anion gap. Urine organic acid analysis by GC-MS [13]
revealed marked elevation of methylmalonic acid.
Enzyme assay
Leukocytes were extracted and MCM activity as-
sayed as previously described with reduced reagent
volumes [14,15]. The Km of methylmalonyl-CoA was
determined in 105 lM deoxyadenosyl cobalamin, while
the Km of deoxyadenosyl cobalamin was determined in
380 lM methylmalonyl-CoA.
MCM gene ampliﬁcation and sequencing
Total RNA was extracted from the leukocytes using
a Qiagen blood RNA kit (Qiagen GmbH, Hilden,erved.
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PCR, as previously described [4], and directly sequenced.
For analysis of the allelic segregation, the cDNA were
cloned into pGEMT vectors (Promega, Madison, WI)
and sequenced. Genomic DNA was prepared using a
Qiamp DNA minikit (Qiagen). To analyze the 1048delT
mutation, exon 5 was PCR ampliﬁed using the For987
and Rev1131 primers [4]. Exons 8 and 9 were ampliﬁed
with the ﬂanking primers, Ex8F (50-GAAAATACATC
ATAACCAGAGCA-30) and Ex8R (50-TAATACACA
CCTCATGCTGTTG-30) for exon 8, and Ex9F (50-CA
TCAGGGTCTAATCTCTTGAT-30) and Ex9R (50-TC
ACATGGTTTACAGGATCAAC-30) for exon 9, to
detect the A499T and G544X mutations, respectively.
The 1048delT mutation was conﬁrmed by cleavage of
the exon 5 PCR product with AluI restriction endonu-
clease (New England BioLabs, Beverly, MA).
MCM expression in Escherichia coli
The mRNA of the proband and a normal control were
reverse-transcribed and PCR ampliﬁed using Pfu poly-
merase (Promega) and the primers MCMF-NcoI (50-AT
TTCCATGGTACACCAGCAACAGCCCCT-30) and
MCMR-SacI (50-ATTTGAGCTCTCTCTTCTTTGAT
CATAACTA-30) to add NcoI and SacI sites, cloned
into these sites in pET32a and pET23d (Novagen, Mad-
ison, WI), and sequenced. To isolate the A499T and
G544Xmutations from other mutations and PCR errors,
nucleotides 1160–1741 containing these mutations were
excised with BamHI and NsiI, and ligated into the
corresponding sites in theMCMcDNA expression vector
to create single mutant expression vectors. These
constructs were used for protein expression, and the
E. coli cell extracts assayed forMCMactivity and protein
content, as previously described [16].Results and discussion
The proband had typical clinical presentation and
urine organic acid pattern of MMA. No MCM activity
could be detected in leukocyte extracts from the pro-
band, whereas activity was detected in all normal con-
trols (121 50 pmol succinyl-CoA produced/min/mg
protein) and in the parents (78 and 52 pmol/min/mg for
the mother and father, respectively).
The probands cDNA had three heterozygous nucle-
otide changes: 1571G>A (A499T), 1706G>T, and
1707G>A, with the later two on the same allele to give
1706_1707delGGinsTA (G544X), and one heterozygous
single base deletion, 1048delT. The previously described
polymorphism H532R [5] was homozygous in all cDNA
from this family and in three Thai controls. None of the
new mutations were clearly detected in the mRNA from
the parents, but genomic DNA sequence showed that themother was heterozygous for the 1048delT and A499T
mutations, while the father was heterozygous for the
G544X mutation. The presence of the 1048delT muta-
tion in the proband and her mother, but not the father,
could be conﬁrmed by PCR ampliﬁcation of exon 5,
followed by AluI digest. The mutation eliminates an AluI
site, resulting in only approximately half the PCR
product being digested in the mother and patient. The
inability to detect the mutations in the parents mRNA
may indicate that the mutant mRNAs are less stable than
the normal MCM mRNA. The 1048delT deletion causes
a frameshift at Ala324, resulting in a change of the next
eight residues from GRRLWAHL to VEDSGLT (stop),
so both new mutations result in premature stop codons.
The instability of MCM mRNA with premature stop
codons has been noted in the past for other mutations
resulting in premature stop codons [11].
The A499T change in this patient would not have any
eﬀect, since it comes after the 1048delT frameshift, but it
is unclear whether it might aﬀect other patients. Berger
et al. [17] reported it in association with the mutation
IVS8+ 3a> g, which apparently caused a high fre-
quency of incorrect splicing. They suggested that the
A499T mutation had no aﬀect, since the position is not
evolutionarily conserved. This mutation did not seem to
aﬀect the splicing, since no mis-spliced mRNA was de-
tected here. MCM speciﬁc activities in extracts of E. coli
expressing thioredoxin–MCM fusion proteins with
normal MCM cDNA and A499T cDNA were high and
similar (8.53 103 and 8.11 103 pmol succinyl-CoA/
mg/min), while those with the G544X mutation had no
activity. Expression of MCM without the N-terminal
thioredoxin fusion protein gave similar results. The Km
values of the normal and A499T MCM for the cofactor,
deoxyadenosyl-cobalamin, in the presence of 0.38mM
substrate were 0.26 and 0.19 lM, respectively, while Km
values for the substrate, methylmalonyl-CoA, were 0.13
and 0.14mM, respectively. Thus, the A499T MCM en-
zyme appeared normal in terms of binding cofactor and
substrate and catalyzing the mutase reaction. Analysis
of 100 Thai controls found this polymorphism repre-
sented 8.0% of the alleles (16 of 200 chromosomes).
The patient appeared to be a compound heterozygote
for two new mutations, 1048delT and G544X. Both
mutants are expected to produce a protein with a trun-
cated MCM domain and no cobalamin-binding domain
[18,19], so no MCM activity is expected. The A499T
polymorphism, however, seemed to produce a normal
enzyme in the recombinant system, and was found to be
a frequent allele in the normal Thai population.Acknowledgments
This work was supported by grants from the Chu-
labhorn Research Institute and the Thailand Research
302 V. Champattanachai et al. / Molecular Genetics and Metabolism 79 (2003) 300–302Fund; contract number RTA/02/2544 and RSA/05/2544.
The authors are indebted to the patients family for
enthusiastic participation.References
[1] W.A. Fenton, R.A. Gravel, L.E. Rosenberg, Disorders of
propionate and methylmalonate metabolism, in: C.R. Scriver,
A.L. Beaudet, W.s. Sly, D. Valle (Eds.), The Metaboic and
Molecular Basis of Inherited Disease, eight ed., McGraw-Hill,
New York, 2001, pp. 2165–2194.
[2] C.M. Dobson, T. Wai, D. Leclerc, A. Wilson, X. Wu, C. Dore,
T. Hudson, D.S. Rosenblatt, R.A. Gravel, Identiﬁcation of the
gene responsible for the cblA complementation group of vitamin
B12-responsive methylmalonic acidemia based on analysis of
prokaryotic gene arrangements, Proc. Natl. Acad. Sci. USA 99
(2002) 15554–15559.
[3] C.M. Dobson, T. Wai, D. Leclerc, H. Kadir, M. Narang, J.P.
Lerner-Ellis, T.J. Hudson, D.S. Rosenblatt, R.A. Gravel, Identi-
ﬁcation of the gene responsible for the cblB complementation
group of vitamin B12-dependent methylmalonic aciduria, Hum.
Mol. Genet. 11 (2002) 3361–3369.
[4] R. Jansen, F.D. Ledley, Heterozygous mutations at the mut locus
in ﬁbroblasts with mut0 methylmalonic acidemica identﬁed by
polymerase-chain reaction cDNA cloning, Am. J. Hum. Genet. 47
(1990) 808–814.
[5] A.M. Crane, R. Jansen, E.R. Andrews, F.D. Ledley, Cloning and
expression of a mutant methylmalonyl coenzyme A mutase with
altered cobalamin aﬃnity that causes mut methylmalonic acid-
uria, J. Clin. Invest. 89 (1992) 385–391.
[6] F.D. Ledley, D.S. Rosenblatt, Mutations in mut methylmalonic
acidemia: clinical and enzymatic correlations, Hum. Mutat. 9
(1997) 1–6.
[7] C.E. Adjalla, A.R. Hosack, B.M. Gilﬁx, E. Lamothe, S. Sun,
A. Chan, S. Evans, N.V. Matiaszuk, D.S. Rosenblatt, Seven novel
mutations in mut methylmalonic aciduria, Hum. Mutat. 11 (1998)
270–274.
[8] A. Fuchshuber, B. Mucha, E.R. Baumgartner, M. Vollmer,
F. Hildebrandt, mut0 methylmalonic acidemica: eleven novel
mutations of the methylmalonyl-CoA mutase including a dele-
tion-insertion mutation, Hum. Mutat. 16 (2000) 179.
[9] J.-F. Benoist, C. Acquaviva, I. Callebaut, N. Guﬀon, H. Ogier de
Baulny, J.-.P. Mornon, D. Porquet, J. Elion, Molecular and
structural analysis of two novel mutations in a patient with mutmethylmalonyl-CoA deﬁciency, Mol. Genet. Metabol. 72 (2001)
181–184, doi:10.1006/mgme.2000.3122.
[10] H.L. Peters, M. Nefedov, L.W. Lee, J.E. Abdenur, N.A. Chamo-
les, S.G. Kahler, P.A. Ioannou, Molecular studies in mutase-
deﬁcient (MUT) methylmalonic aciduria: identiﬁcation of ﬁve
novel mutations, Hum. Mutat. 20 (2002) 406.
[11] M. Ogasawara, Y. Matsubara, H. Mikami, K. Narisawa, Iden-
tiﬁcation of two novel mutations in the methylmalonyl-CoA
mutase gene with decreased levels of mutant mRNA in meth-
ylmalonic acidemia, Hum. Mol. Genet. 3 (1994) 867–872.
[12] H. Mikami, M. Ogasawara, Y. Matubara, M. Kikuchi,
S. Miyabayashi, S. Kure, K. Narisawa, Molecular analysis of
methylmalonyl-CoA mutase deﬁciency: identﬁcation of three
missense mutations in mut0 patients, J. Hum. Genet. 44 (1999)
35–39.
[13] V. Shotelersuk, S. Srivuthana, S. Wacharasindhu, V. Dham-
charee, S. Jaruratanasirikul, S. Pangkanon, V. Kaewpaluek,
S. Aroonparkmongkol, Establishing gas chromatography–mass
spectrometry to diagnose organic acidemias in Thailand,
Southeast Asian J. Trop. Med. Public Health 31 (2000) 566–
570.
[14] B. Riedel, P.M. Ueland, A.M. Svardal, Fully automated assay for
cobalamin-dependent methymalonyl CoA mutase, Clin. Chem. 41
(1995) 1164–1170.
[15] M. Kikuchi, H. Hanamizu, K. Narisawa, K. Tada, Assay of
methylmalonyl CoA mutase with high-performance liquid chro-
matography, Clin. Chim. Acta 184 (1989) 307–314.
[16] J. Janata, N. Kogekar, W.A. Fenton, Expression and kinetic
characterization of methylmalonyl-CoA mutase from patients
with the mut phenotype: evidence for naturally occurring
interallelic complementation, Hum. Mol. Genet. 6 (1997) 1457–
1464.
[17] I. Berger, A. Shaag, Y. Anikster, E.R. Baumgartner, M. Bar-Meir,
A. Joseph, O.N. Elpeleg, Mutation analysis of the MCM gene in
Israeli patients with mut0 disease, Mol. Genet. Metabol. 73 (2001)
107–110, doi:10.1006/mgme.2001.3166.
[18] F. Mancia, N.H. Keep, A. Nakagawa, P. Leadlay, S. McSweeney,
B. Rasmussen, P. Bosecke, O. Diat, P.R. Evans, How coenzyme
B12 radicals are generated: the crystal structure of methylmalo-
nyl-coenzyme A mutase at 2A resolution, Structure 4 (1996) 339–
350.
[19] C.L. Drennen, R.G. Matthews, D.S. Rosenblatt, F.D. Ledley,
W.A. Fenton, M.L. Ludwig, Molecular basis for dysfunction of
some mutant forms of methymalonyl-CoA mutase: deductions
from the structure of methionine synthase, Proc. Natl. Acad. Sci.
USA 93 (1996) 5550–5555.
